Creo Medical Group PLC
LSE:CREO
Creo Medical Group PLC
LSE:CREO
Price:
10.875
GBX
-2.25%
Market Closed
Market Cap:
£44.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Creo Medical Group PLC
LSE:CREO
|
UK |
|
Z
|
ZAZZ Energy of Sweden AB (publ)
STO:ZAZZ B
|
SE |
|
Almirall SA
F:E2Z
|
ES |
|
W
|
Wiscom System Co Ltd
SZSE:002090
|
CN |
|
D
|
Danel Adir Yeoshua Ltd
TASE:DANE
|
IL |
|
E
|
EZZ Life Science Holdings Ltd
ASX:EZZ
|
AU |
|
H
|
Henan Shijia Photons Technology Co Ltd
SSE:688313
|
CN |
|
Viva Energy Group Ltd
ASX:VEA
|
AU |
Multiples-Based Value
The
Multiples-Based Value for
Creo Medical Group PLC (CREO)
under the Base Case is
hidden
GBX.
Compared with the current market price of 10.875 GBX, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CREO Multiples-Based Value
LOCKED
Multiples Across Competitors
CREO Competitors Multiples
Creo Medical Group PLC Competitors
Creo Medical Group PLC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
|
Creo Medical Group PLC
LSE:CREO
|
44.9m GBP | 20.4 | 2.7 | -3 | -2.6 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
178.4B USD | 4 | 27.3 | 15.7 | 21.5 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
161.5B USD | 16 | 56.6 | 42.8 | 52.6 | |
| US |
|
Stryker Corp
NYSE:SYK
|
129.7B USD | 5.2 | 40 | 20.4 | 24.7 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
112.8B USD | 3.2 | 24.5 | 13.5 | 19.7 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
90.9B USD | 4.5 | 31.4 | 18.6 | 25 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
42.1B EUR | 1.8 | 20 | 11.2 | 15.8 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46B USD | 7.6 | 42.8 | 23.5 | 25.7 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
46.6B USD | 10.8 | 44 | 31.2 | 34.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.3B USD | 2 | 25.2 | 10 | 16.9 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
33.2B USD | 1.6 | 15.9 | 11.5 | 13.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
